EU medical compliance Archives | ۿ۴ý The design Experts Wed, 14 Feb 2024 07:13:28 +0000 en-US hourly 1 Conflict Minerals Compliance: FREQUENTLY ASKED QUESTIONS /blog/conflict-minerals-compliance-frequently-asked-questions/ Wed, 14 Oct 2015 17:34:07 +0000 https://enventure.com/?p=4288 While handling environmental compliances, suppliers and manufacturers from various industries face multiple challenges. After having provided successful compliance services to the all our Clients across

The post Conflict Minerals Compliance: FREQUENTLY ASKED QUESTIONS appeared first on ۿ۴ý.

]]>
While handling environmental compliances, suppliers and manufacturers from various industries face multiple challenges. After having provided successful compliance services to the all our Clients across geographies, we decided to compile our set of frequently asked questions pertaining to . Below is the set for your reference: 1. What if a company decides not to comply with Section 1502 or SEC filing? If a company does not comply with the laws of SEC, it will not be able to raise new capital under the Exchange Act. 2. Is SEC filing applicable for private companies? Private companies are not required to file annual reports under SEC but if their customers are publicly-traded on the US stock exchange and are liable to file conflict minerals report, then the company should also report under SEC on the Origin and mining procedures of the minerals. 3. Which framework can be suggested for due diligence process? Due diligence process should be carried out by a nationally or internationally recognized framework. Currently the only recognized framework is OECD (Organization for Economic Cooperation & Development) which performs Due Diligence Guidance for Responsible Supply Chain of Minerals from Conflict-Affected and High-Risk Areas. 4. When will an issuer NOT be considered as “contract to manufacture”? In the following cases the issuer cannot be considered as “contract to manufacture”
  • If the issuer is involved in
    • Specifying or negotiating contractual terms with manufacturer
    • Affixing brand, logo, marks or label to a generic product
    • Services, maintenance or repair activity
  • If the issuer is not directly or indirectly involved in manufacturing process
5. What do you mean by “DRC conflict free”? “DRC conflict free” means the product manufactured does not contain any of the 4 conflict minerals (Tantalum, Tin, Gold and Tungsten) that have been identified to directly or indirectly benefiting militants in the DRC- Democratic Republic of Congo, countries. 6. When can an issuer describe the products as “DRC conflict undeterminable”? If the issuer is not able to determine that the conflict minerals mined from DRC countries, are benefiting armed groups even after due diligence process then the products are considered to be “DRC conflict undeterminable”. The undeterminable status of the product would be based on the due diligence process (conducted by OECD). 7. Can a company provide Conflict minerals policy stating that “we are conflict free”? No. For most cases a conflict minerals compliance process is recommended. However in certain cases, if a company chooses to provide complete due diligence information and supporting data in the form of CMRT to prove that its products are conflict free, Policy statement can be accepted. Due diligence for conflict minerals is a mandatory requirement that cannot be evaded. 8. Which CMRT should be used for 2016 filings? We recommend to use the latest CMRT v4.01a which has been released after examining the errors in the prior versions. Moreover, the most updated Standard smelter list is included in CMRT v4.01a.
Need assistance in managing your conflict minerals compliance?

The post Conflict Minerals Compliance: FREQUENTLY ASKED QUESTIONS appeared first on ۿ۴ý.

]]>
RoHS Compliance Marking for Medical Devices /blog/rohs-compliance-marking-medical-devices/ Thu, 11 Dec 2014 10:52:19 +0000 https://enventure.com/?p=2564 While the previous version of RoHS directive did not require any special mark to demonstrate RoHS compliance, under the recast, it became mandatory that all

The post RoHS Compliance Marking for Medical Devices appeared first on ۿ۴ý.

]]>
While the previous version of RoHS directive did not require any special mark to demonstrate RoHS compliance, under the recast, it became mandatory that all equipment covered by RoHS must now bear the CE mark.

As a symbol, CE mark is familiar for everyone as it has been a mandatory requirement for many years on products sold in the European Union. After the recast of the , it has also become the proof of conformity of the product to the European RoHS directive. The mark must be displayed on the product visibly, legibly and indelibly. Manufacturers, importers and distributors are responsible for ensuring that the mark is properly placed on EEE.

The CE marking indicates a product’s compliance with EU legislation. By affixing the CE marking to a product, a manufacturer declares his sole responsibility, that the product meets all the legal requirements, which means that the product can be sold across the European Economic Area.

RoHS 2 brings about a few other significant changes related to the broader scope of the directive which has implications on the legal responsibilities of businesses. Some of these changes affect manufacturers directly, as they are required to:

  • Issue a signed Declaration of Conformity (DoC).
  • Create a technical documentation file as per EN 50581:2012 or equivalent standards that meet requirements of module A of Annex II to decision 768/2008/EC.
  • Accept analytical material test results as per the IEC 62321 Standard.
  • Keep the DoC and technical documentation file for a longer period after the product has been placed in the market.

Obtain the CE marking, to prove RoHS 2 compliance.

Obligations for medical device manufacturers

Now, since the medical devices also fall within the scope of RoHS2 directive (2011/65/EU), Medical Device manufacturers are obligated to ensure and demonstrate compliance with the directive.

If a medical device is correctly CE marked and has the relevant documents for verification, the product does not need any additional approval or certification to be marketed in the European Union (EU), European Economic Area (EEA) or Switzerland as CE marking allows free movement of goods in these states.

The CE mark is a legal designation that the manufacturer’s product has met the requirements of all relevant Medical Device Directives as laid down by EU (93/42/EEC or 90/385/EEC or 98/79/EC).

In order to demonstrate compliance with the RoHS 2 recast, Medical Device Manufacturers are required to

  •  Define their product and identify the directives applicable to it.
  •  Source RoHS compliant material from suppliers, analyze and identify material changes needed to comply with the RoHS 2 directive.
  •  Show proof of RoHS 2 compliance by drawing up required technical documentation surrounding their product including conformity risk assessment reports, test reports for each part.
  • Draw up an EC declaration of Conformity
  • Affix the ‘CE’ mark on the finished product and start to sell.

CE Marking is now a mandate for , manufacturers must draw up the required technical documentation, carry out an internal production control procedure, draw up an EC declaration of conformity and affix the ‘CE’ mark to their product.

It is the manufacturer’s responsibility to carry out the conformity assessment, to set up the technical file, to issue the declaration of conformity and to affix the CE marking to a product. Distributors must check that the product bears the CE marking and that the requisite supporting documentation is in order. If the product is being imported from outside the EEA, the importer has to verify that the manufacturer has undertaken the necessary steps and that the documentation is available upon request.

According to the other Medical Device Directives in the EU, subject to the type of the device, manufacturers require to have their quality systems and technical documentation reviewed by a Notified Body before they can place their products on the market as part of the conformity assessment procedure.

However, RoHS 2 outlines surveillance responsibilities of member states but does not contain a mandate for Notified Body assessment of compliance with the RoHS 2 provisions. Only products which are designated as high risk to public interest require conformity assessment by a Notified Body. Unless there are grounds for suspecting that a device may pose a risk to public health, member states must not create any obstacles to the placing on the market or the putting into service of any medical devices as defined under the Directive bearing a legitimate CE marking.

Since most of the CE standards that apply to products are harmonized, entry of the product into EU market only requires conformance to a single set of standards, this simplifies the process of entering the EU market for medical device manufacturers and also demonstrates the importance of obtaining the ‘CE’ mark.

The post RoHS Compliance Marking for Medical Devices appeared first on ۿ۴ý.

]]>